Last reviewed · How we verify

BXCL501 120 Micrograms

BioXcel Therapeutics Inc · Phase 1 active Small molecule

At a glance

Generic nameBXCL501 120 Micrograms
Also known asDexmedetomidine
SponsorBioXcel Therapeutics Inc
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.